Main Reasons Why Continuous Manufacturing Can Help the Pharmaceutical Industry Transform

 

linkedin.com

Due to continuous processing, pharmaceutical supply chains can benefit from significant innovations that happen to be commonplace in most other industries. Adoption of such a capability will lead to some main benefits, based on David Topper:

Manufacturing flexibility in nearly any place

The ability to mount manufacturing processes on self-sufficient transportable platforms, with the capability of becoming transported to exactly where manufacturing is required, plugged in, and operated with minimal interference, enables for as much as an 80% reduction inside the important footprint of continuous unit operations. Not only does this open up the possibility of streamlining supply chains with regards to operational expenses, but it also opens up the possibility of tax added benefits from the manufacture and transfer of solutions involving countries.

Scale-up and scale-down of production inside a brief period

Fluctuating solution demand is usually difficult to handle, which has been amplified in the last 12 months. Even though existing systems struggle with fixed batch sizes, extended manufacturing lead instances and severely limited manufacturing runs, a continuous manufacturing unit supplies the flexibility to produce the quantity of material required with all the shortest possible lead time. A second identical unit could be flown in and run alongside it if it reaches capacity, applying the 'scale-out strategy of growing throughput.

Digitization and automation

The steady-state' of continuous unit operations simplifies some aspects of digital-twin manufacturing approach modeling. This has the advantage of allowing Efficiency Analytics Technologies (PAT) testing to ascertain the high-quality from the solution leaving the process, which has already been established to allow real-time excellent release instead of the present two-week minimum delay whilst solution high-quality is assured.